IVVD Q4 2024 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M

Gross Profit

$13M94.8% margin

Operating Income

-$19M-139.1% margin

Net Income

-$18M-133.5% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+48.6%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$130M

Total Liabilities

$62M

Stockholders' Equity

$68M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$0	—
Gross Profit	$13M	$0	—
Operating Income	-$19M	-$77M	+74.9%
Net Income	-$18M	-$74M	+75.0%

Revenue Segments

Product

$14M100%